May 27, 2015
The Ministry of Health, Labor and Welfare (MHLW) approved on May 26 an additional indication of adjuvant therapy for malignant melanoma for MSD’s Pegintron Powder for Injection (recombinant peginterferon alfa-2b). The MHLW also approved additional indications for: 1) Mitsubishi Tanabe...read more